In 2020, a mid-sized pharmaceutical company faced a dilemma. Their R&D workflows were scattered across spreadsheets, emails, and disconnected systems. Each new drug trial involved thousands of steps, approvals, and regulatory checks. Delays weren’t j...
No responses yet.